Drug delivery formulation for treating mental illness or central nervous system disorder

    公开(公告)号:US11337929B2

    公开(公告)日:2022-05-24

    申请号:US16484870

    申请日:2018-02-08

    Abstract: A drug delivery formulation for treating a mental illness or a central nervous system disorder is disclosed. The drug delivery formulation includes a microcapsule containing a biodegradable polymer and a drug and a crosslinked hydrogel and a method for preparing the same. The drug delivery formulation can slowly release a drug at a constant rate without a burst of drug release in the early stage of drug administration to maintain a constant blood drug level over a long period of time and thus enjoys the advantage of preventing excessive initial release of drug, thereby obtaining a desirable sustained release profile by single administration without necessity for multiple administrations divided at regular time intervals.

Patent Agency Ranking